APO Research
Talk to an analyst

APO RESEARCH · REPORT

Propranolol Tablet

Compare research editions
View pricing & licenses

Selected research

Industry Research

Propranolol Tablet Industry Research Report 2026

22 December 2025138 pages

Choose your research edition.

Industry ResearchPropranolol Tablet Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Propranolol Tablet Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Propranolol Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propranolol Tablet Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Propranolol Tablet Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Propranolol Tablet market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Propranolol Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Propranolol Tablet is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Propranolol Tablet is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Propranolol Tablet include AbZ-Pharma GmbH, Apotex, Atnas Pharma, IFET, Intas Pharma, Iqfarma, Nichi-Iko Pharmaceutical, Sawai Seiyaku and Towa Yakuhin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Propranolol Tablet market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Propranolol Tablet Market by Company

AbZ-Pharma GmbH

Apotex

Atnas Pharma

IFET

Intas Pharma

Iqfarma

Nichi-Iko Pharmaceutical

Sawai Seiyaku

Towa Yakuhin

Zentiva

Zydus Pharma

Yabang Pharma

Mylan

Novartis

Sanofi

Teva

Propranolol Tablet Segment by Type

60mg

40mg

20mg

Other

Propranolol Tablet Segment by Application

Atrial Fibrillation

Myocardial Infarction

Angina

Other

Propranolol Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propranolol Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propranolol Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propranolol Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Propranolol Tablet manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Propranolol Tablet by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Propranolol Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Propranolol Tablet Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Propranolol Tablet Sales (k units) of Manufacturers (2021-2026) Table 7. Global Propranolol Tablet Sales Market Share by Manufacturers (2021-2026) Table 8. Global Propranolol Tablet Revenue of Manufacturers (2021-2026) Table 9. Global Propranolol Tablet Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Propranolol Tablet Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Propranolol Tablet Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Propranolol Tablet, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Propranolol Tablet, Product Type & Application Table 14. Global Propranolol Tablet Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Propranolol Tablet by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. AbZ-Pharma GmbH Company Information Table 19. AbZ-Pharma GmbH Business Overview Table 20. AbZ-Pharma GmbH Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. AbZ-Pharma GmbH Propranolol Tablet Product Portfolio Table 22. AbZ-Pharma GmbH Recent Developments Table 23. Apotex Company Information Table 24. Apotex Business Overview Table 25. Apotex Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Apotex Propranolol Tablet Product Portfolio Table 27. Apotex Recent Developments Table 28. Atnas Pharma Company Information Table 29. Atnas Pharma Business Overview Table 30. Atnas Pharma Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Atnas Pharma Propranolol Tablet Product Portfolio Table 32. Atnas Pharma Recent Developments Table 33. IFET Company Information Table 34. IFET Business Overview Table 35. IFET Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. IFET Propranolol Tablet Product Portfolio Table 37. IFET Recent Developments Table 38. Intas Pharma Company Information Table 39. Intas Pharma Business Overview Table 40. Intas Pharma Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Intas Pharma Propranolol Tablet Product Portfolio Table 42. Intas Pharma Recent Developments Table 43. Iqfarma Company Information Table 44. Iqfarma Business Overview Table 45. Iqfarma Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Iqfarma Propranolol Tablet Product Portfolio Table 47. Iqfarma Recent Developments Table 48. Nichi-Iko Pharmaceutical Company Information Table 49. Nichi-Iko Pharmaceutical Business Overview Table 50. Nichi-Iko Pharmaceutical Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Nichi-Iko Pharmaceutical Propranolol Tablet Product Portfolio Table 52. Nichi-Iko Pharmaceutical Recent Developments Table 53. Sawai Seiyaku Company Information Table 54. Sawai Seiyaku Business Overview Table 55. Sawai Seiyaku Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Sawai Seiyaku Propranolol Tablet Product Portfolio Table 57. Sawai Seiyaku Recent Developments Table 58. Towa Yakuhin Company Information Table 59. Towa Yakuhin Business Overview Table 60. Towa Yakuhin Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Towa Yakuhin Propranolol Tablet Product Portfolio Table 62. Towa Yakuhin Recent Developments Table 63. Zentiva Company Information Table 64. Zentiva Business Overview Table 65. Zentiva Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Zentiva Propranolol Tablet Product Portfolio Table 67. Zentiva Recent Developments Table 68. Zydus Pharma Company Information Table 69. Zydus Pharma Business Overview Table 70. Zydus Pharma Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Zydus Pharma Propranolol Tablet Product Portfolio Table 72. Zydus Pharma Recent Developments Table 73. Yabang Pharma Company Information Table 74. Yabang Pharma Business Overview Table 75. Yabang Pharma Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Yabang Pharma Propranolol Tablet Product Portfolio Table 77. Yabang Pharma Recent Developments Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Mylan Propranolol Tablet Product Portfolio Table 82. Mylan Recent Developments Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Novartis Propranolol Tablet Product Portfolio Table 87. Novartis Recent Developments Table 88. Sanofi Company Information Table 89. Sanofi Business Overview Table 90. Sanofi Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Sanofi Propranolol Tablet Product Portfolio Table 92. Sanofi Recent Developments Table 93. Teva Company Information Table 94. Teva Business Overview Table 95. Teva Propranolol Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Teva Propranolol Tablet Product Portfolio Table 97. Teva Recent Developments Table 98. Global Propranolol Tablet Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Propranolol Tablet Sales by Region (2021-2026) & (k units) Table 100. Global Propranolol Tablet Sales Market Share by Region (2021-2026) Table 101. Global Propranolol Tablet Sales by Region (2027-2032) & (k units) Table 102. Global Propranolol Tablet Sales Market Share by Region (2027-2032) Table 103. Global Propranolol Tablet Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Propranolol Tablet Revenue Market Share by Region (2021-2026) Table 105. Global Propranolol Tablet Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Propranolol Tablet Revenue Market Share by Region (2027-2032) Table 107. North America Propranolol Tablet Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Propranolol Tablet Sales by Country (2021-2026) & (k units) Table 109. North America Propranolol Tablet Sales by Country (2027-2032) & (k units) Table 110. North America Propranolol Tablet Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Propranolol Tablet Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Propranolol Tablet Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Propranolol Tablet Sales by Country (2021-2026) & (k units) Table 114. Europe Propranolol Tablet Sales by Country (2027-2032) & (k units) Table 115. Europe Propranolol Tablet Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Propranolol Tablet Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Propranolol Tablet Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Propranolol Tablet Sales by Country (2021-2026) & (k units) Table 119. Asia Pacific Propranolol Tablet Sales by Country (2027-2032) & (k units) Table 120. Asia Pacific Propranolol Tablet Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Propranolol Tablet Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Propranolol Tablet Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Propranolol Tablet Sales by Country (2021-2026) & (k units) Table 124. South America Propranolol Tablet Sales by Country (2027-2032) & (k units) Table 125. South America Propranolol Tablet Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Propranolol Tablet Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Propranolol Tablet Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Propranolol Tablet Sales by Country (2021-2026) & (k units) Table 129. Middle East and Africa Propranolol Tablet Sales by Country (2027-2032) & (k units) Table 130. Middle East and Africa Propranolol Tablet Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Propranolol Tablet Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Propranolol Tablet Sales by Type (2021-2026) & (k units) Table 133. Global Propranolol Tablet Sales by Type (2027-2032) & (k units) Table 134. Global Propranolol Tablet Sales Market Share by Type (2021-2026) Table 135. Global Propranolol Tablet Sales Market Share by Type (2027-2032) Table 136. Global Propranolol Tablet Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Propranolol Tablet Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Propranolol Tablet Revenue Market Share by Type (2021-2026) Table 139. Global Propranolol Tablet Revenue Market Share by Type (2027-2032) Table 140. Global Propranolol Tablet Price by Type (2021-2026) & (US$/unit) Table 141. Global Propranolol Tablet Price by Type (2027-2032) & (US$/unit) Table 142. Global Propranolol Tablet Sales by Application (2021-2026) & (k units) Table 143. Global Propranolol Tablet Sales by Application (2027-2032) & (k units) Table 144. Global Propranolol Tablet Sales Market Share by Application (2021-2026) Table 145. Global Propranolol Tablet Sales Market Share by Application (2027-2032) Table 146. Global Propranolol Tablet Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Propranolol Tablet Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Propranolol Tablet Revenue Market Share by Application (2021-2026) Table 149. Global Propranolol Tablet Revenue Market Share by Application (2027-2032) Table 150. Global Propranolol Tablet Price by Application (2021-2026) & (US$/unit) Table 151. Global Propranolol Tablet Price by Application (2027-2032) & (US$/unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Propranolol Tablet Distributors List Table 155. Propranolol Tablet Customers List Table 156. Propranolol Tablet Industry Trends Table 157. Propranolol Tablet Industry Drivers Table 158. Propranolol Tablet Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Propranolol Tablet Product Image Figure 5. Global Propranolol Tablet Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Propranolol Tablet Market Size (2021-2032) & (US$ Million) Figure 7. Global Propranolol Tablet Sales (2021-2032) & (k units) Figure 8. Global Propranolol Tablet Average Price (US$/unit) & (2021-2032) Figure 9. 60mg Product Image Figure 10. 40mg Product Image Figure 11. 20mg Product Image Figure 12. Other Product Image Figure 13. Atrial Fibrillation Product Image Figure 14. Myocardial Infarction Product Image Figure 15. Angina Product Image Figure 16. Other Product Image Figure 17. Global Propranolol Tablet Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Propranolol Tablet, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Propranolol Tablet Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Propranolol Tablet Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Propranolol Tablet Sales by Region in 2025 Figure 23. Global Propranolol Tablet Revenue by Region in 2025 Figure 24. North America Propranolol Tablet Market Size by Country in 2025 Figure 25. North America Propranolol Tablet Sales Market Share by Country (2021-2032) Figure 26. North America Propranolol Tablet Revenue Market Share by Country (2021-2032) Figure 27. United States Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Propranolol Tablet Market Size by Country in 2025 Figure 31. Europe Propranolol Tablet Sales Market Share by Country (2021-2032) Figure 32. Europe Propranolol Tablet Revenue Market Share by Country (2021-2032) Figure 33. Germany Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Propranolol Tablet Market Size by Country in 2025 Figure 44. Asia Pacific Propranolol Tablet Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Propranolol Tablet Revenue Market Share by Country (2021-2032) Figure 46. China Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Propranolol Tablet Market Size by Country in 2025 Figure 55. South America Propranolol Tablet Sales Market Share by Country (2021-2032) Figure 56. South America Propranolol Tablet Revenue Market Share by Country (2021-2032) Figure 57. Brazil Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Colombia Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Middle East and Africa Propranolol Tablet Market Size by Country in 2025 Figure 62. Middle East and Africa Propranolol Tablet Sales Market Share by Country (2021-2032) Figure 63. Middle East and Africa Propranolol Tablet Revenue Market Share by Country (2021-2032) Figure 64. Egypt Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. South Africa Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Israel Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Türkiye Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. GCC Countries Propranolol Tablet Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Global Propranolol Tablet Sales Market Share by Type (2021-2032) Figure 70. Global Propranolol Tablet Revenue Market Share by Type (2021-2032) Figure 71. Global Propranolol Tablet Price (US$/unit) by Type (2021-2032) Figure 72. Global Propranolol Tablet Sales Market Share by Application (2021-2032) Figure 73. Global Propranolol Tablet Revenue Market Share by Application (2021-2032) Figure 74. Global Propranolol Tablet Price (US$/unit) by Application (2021-2032) Figure 75. Propranolol Tablet Value Chain Figure 76. Propranolol Tablet Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Propranolol Tablet Industry Opportunities and Challenges

Scope & coverage.

Types
  • 60mg
  • 40mg
  • 20mg
  • Other
Applications
  • Atrial Fibrillation
  • Myocardial Infarction
  • Angina
  • Other
Companies covered
  • AbZ-Pharma GmbH
  • Apotex
  • Atnas Pharma
  • IFET
  • Intas Pharma
  • Iqfarma
  • Nichi-Iko Pharmaceutical
  • Sawai Seiyaku
  • Towa Yakuhin
  • Zentiva
  • Zydus Pharma
  • Yabang Pharma
  • Mylan
  • Novartis
  • Sanofi
  • Teva

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Propranolol Tablet Market Size (2021-2032)
  4. 2.2.2 Global Propranolol Tablet Sales (2021-2032)
  5. 2.2.3 Global Propranolol Tablet Market Average Price (2021-2032)
  6. 2.3 Propranolol Tablet by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 60mg
  9. 2.3.3 40mg
  10. 2.3.4 20mg
  11. 2.3.5 Other
  12. 2.4 Propranolol Tablet by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Atrial Fibrillation
  15. 2.4.3 Myocardial Infarction
  16. 2.4.4 Angina
  17. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Propranolol Tablet Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Propranolol Tablet Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Propranolol Tablet Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Propranolol Tablet Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Propranolol Tablet Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Propranolol Tablet, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Propranolol Tablet, Product Type & Application
  8. 3.8 Global Manufacturers of Propranolol Tablet, Established Date
  9. 3.9 Global Propranolol Tablet Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 AbZ-Pharma GmbH
  2. 4.1.1 AbZ-Pharma GmbH Company Information
  3. 4.1.2 AbZ-Pharma GmbH Business Overview
  4. 4.1.3 AbZ-Pharma GmbH Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 AbZ-Pharma GmbH Propranolol Tablet Product Portfolio
  6. 4.1.5 AbZ-Pharma GmbH Recent Developments
  7. 4.2 Apotex
  8. 4.2.1 Apotex Company Information
  9. 4.2.2 Apotex Business Overview
  10. 4.2.3 Apotex Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Apotex Propranolol Tablet Product Portfolio
  12. 4.2.5 Apotex Recent Developments
  13. 4.3 Atnas Pharma
  14. 4.3.1 Atnas Pharma Company Information
  15. 4.3.2 Atnas Pharma Business Overview
  16. 4.3.3 Atnas Pharma Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Atnas Pharma Propranolol Tablet Product Portfolio
  18. 4.3.5 Atnas Pharma Recent Developments
  19. 4.4 IFET
  20. 4.4.1 IFET Company Information
  21. 4.4.2 IFET Business Overview
  22. 4.4.3 IFET Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 IFET Propranolol Tablet Product Portfolio
  24. 4.4.5 IFET Recent Developments
  25. 4.5 Intas Pharma
  26. 4.5.1 Intas Pharma Company Information
  27. 4.5.2 Intas Pharma Business Overview
  28. 4.5.3 Intas Pharma Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Intas Pharma Propranolol Tablet Product Portfolio
  30. 4.5.5 Intas Pharma Recent Developments
  31. 4.6 Iqfarma
  32. 4.6.1 Iqfarma Company Information
  33. 4.6.2 Iqfarma Business Overview
  34. 4.6.3 Iqfarma Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Iqfarma Propranolol Tablet Product Portfolio
  36. 4.6.5 Iqfarma Recent Developments
  37. 4.7 Nichi-Iko Pharmaceutical
  38. 4.7.1 Nichi-Iko Pharmaceutical Company Information
  39. 4.7.2 Nichi-Iko Pharmaceutical Business Overview
  40. 4.7.3 Nichi-Iko Pharmaceutical Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Nichi-Iko Pharmaceutical Propranolol Tablet Product Portfolio
  42. 4.7.5 Nichi-Iko Pharmaceutical Recent Developments
  43. 4.8 Sawai Seiyaku
  44. 4.8.1 Sawai Seiyaku Company Information
  45. 4.8.2 Sawai Seiyaku Business Overview
  46. 4.8.3 Sawai Seiyaku Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sawai Seiyaku Propranolol Tablet Product Portfolio
  48. 4.8.5 Sawai Seiyaku Recent Developments
  49. 4.9 Towa Yakuhin
  50. 4.9.1 Towa Yakuhin Company Information
  51. 4.9.2 Towa Yakuhin Business Overview
  52. 4.9.3 Towa Yakuhin Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Towa Yakuhin Propranolol Tablet Product Portfolio
  54. 4.9.5 Towa Yakuhin Recent Developments
  55. 4.10 Zentiva
  56. 4.10.1 Zentiva Company Information
  57. 4.10.2 Zentiva Business Overview
  58. 4.10.3 Zentiva Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Zentiva Propranolol Tablet Product Portfolio
  60. 4.10.5 Zentiva Recent Developments
  61. 4.11 Zydus Pharma
  62. 4.11.1 Zydus Pharma Company Information
  63. 4.11.2 Zydus Pharma Business Overview
  64. 4.11.3 Zydus Pharma Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Zydus Pharma Propranolol Tablet Product Portfolio
  66. 4.11.5 Zydus Pharma Recent Developments
  67. 4.12 Yabang Pharma
  68. 4.12.1 Yabang Pharma Company Information
  69. 4.12.2 Yabang Pharma Business Overview
  70. 4.12.3 Yabang Pharma Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Yabang Pharma Propranolol Tablet Product Portfolio
  72. 4.12.5 Yabang Pharma Recent Developments
  73. 4.13 Mylan
  74. 4.13.1 Mylan Company Information
  75. 4.13.2 Mylan Business Overview
  76. 4.13.3 Mylan Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Mylan Propranolol Tablet Product Portfolio
  78. 4.13.5 Mylan Recent Developments
  79. 4.14 Novartis
  80. 4.14.1 Novartis Company Information
  81. 4.14.2 Novartis Business Overview
  82. 4.14.3 Novartis Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Novartis Propranolol Tablet Product Portfolio
  84. 4.14.5 Novartis Recent Developments
  85. 4.15 Sanofi
  86. 4.15.1 Sanofi Company Information
  87. 4.15.2 Sanofi Business Overview
  88. 4.15.3 Sanofi Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Sanofi Propranolol Tablet Product Portfolio
  90. 4.15.5 Sanofi Recent Developments
  91. 4.16 Teva
  92. 4.16.1 Teva Company Information
  93. 4.16.2 Teva Business Overview
  94. 4.16.3 Teva Propranolol Tablet Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Teva Propranolol Tablet Product Portfolio
  96. 4.16.5 Teva Recent Developments
5 Global Propranolol Tablet Market Scenario by Region
  1. 5.1 Global Propranolol Tablet Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Propranolol Tablet Sales by Region: 2021-2032
  3. 5.2.1 Global Propranolol Tablet Sales by Region: 2021-2026
  4. 5.2.2 Global Propranolol Tablet Sales by Region: 2027-2032
  5. 5.3 Global Propranolol Tablet Revenue by Region: 2021-2032
  6. 5.3.1 Global Propranolol Tablet Revenue by Region: 2021-2026
  7. 5.3.2 Global Propranolol Tablet Revenue by Region: 2027-2032
  8. 5.4 North America Propranolol Tablet Market Facts & Figures by Country
  9. 5.4.1 North America Propranolol Tablet Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Propranolol Tablet Sales by Country (2021-2032)
  11. 5.4.3 North America Propranolol Tablet Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Propranolol Tablet Market Facts & Figures by Country
  16. 5.5.1 Europe Propranolol Tablet Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Propranolol Tablet Sales by Country (2021-2032)
  18. 5.5.3 Europe Propranolol Tablet Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Propranolol Tablet Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Propranolol Tablet Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Propranolol Tablet Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Propranolol Tablet Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Propranolol Tablet Market Facts & Figures by Country
  41. 5.7.1 South America Propranolol Tablet Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Propranolol Tablet Sales by Country (2021-2032)
  43. 5.7.3 South America Propranolol Tablet Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Propranolol Tablet Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Propranolol Tablet Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Propranolol Tablet Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Propranolol Tablet Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Propranolol Tablet Sales by Type (2021-2032)
  2. 6.1.1 Global Propranolol Tablet Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Propranolol Tablet Sales Market Share by Type (2021-2032)
  4. 6.2 Global Propranolol Tablet Revenue by Type (2021-2032)
  5. 6.2.1 Global Propranolol Tablet Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Propranolol Tablet Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Propranolol Tablet Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Propranolol Tablet Sales by Application (2021-2032)
  2. 7.1.1 Global Propranolol Tablet Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Propranolol Tablet Sales Market Share by Application (2021-2032)
  4. 7.2 Global Propranolol Tablet Revenue by Application (2021-2032)
  5. 7.2.1 Global Propranolol Tablet Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Propranolol Tablet Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Propranolol Tablet Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Propranolol Tablet Value Chain Analysis
  2. 8.1.1 Propranolol Tablet Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Propranolol Tablet Production Mode & Process
  5. 8.2 Propranolol Tablet Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Propranolol Tablet Distributors
  8. 8.2.3 Propranolol Tablet Customers
9 Global Propranolol Tablet Analyzing Market Dynamics
  1. 9.1 Propranolol Tablet Industry Trends
  2. 9.2 Propranolol Tablet Industry Drivers
  3. 9.3 Propranolol Tablet Industry Opportunities and Challenges
  4. 9.4 Propranolol Tablet Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst